UMIN-CTR Clinical Trial

Recruitment status Recruiting
Unique ID issued by UMIN UMIN000025070
Receipt No. R000028794
Official scientific title of the study Association between Total Serum Bilirubin, Heme oxygenase-1, and Urinary Biopyrrins levels and Diabetic retinopathy
Date of disclosure of the study information 2016/12/10
Last modified on 2016/11/30 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Association between Total Serum Bilirubin, Heme oxygenase-1, and Urinary Biopyrrins levels and Diabetic retinopathy
Title of the study (Brief title) Association between Total Serum Bilirubin, Heme oxygenase-1, and Urinary Biopyrrins levels and Diabetic retinopathy
Region
Japan

Condition
Condition Diabetes
Classification by specialty
Endocrinology and Metabolism
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To assess the association between total serum Heme oxygenase-1, bilirubin, and Urinary Biopyrrins levels and Diabetic retinopathy
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Diabetic retinopathy, total serum Heme oxygenase-1, bilirubin, and Urinary Biopyrrins levels
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients with diabetes
Key exclusion criteria Those who decline this study
Target sample size 300

Research contact person
Name of lead principal investigator Toyoshi Inoguchi
Organization Graduate School of Medical Sciences, Kyushu University
Division name Department of Medicine and Bioregulatory
Address 3-1-1, Maidashi, Higashi-ku, Fukuoka City, 812-8582 Japan
TEL 092-642-5284
Email kanakudo@med.kyushu-u.ac.jp

Public contact
Name of contact person Toyoshi Inoguchi
Organization Graduate School of Medical Sciences, Kyushu University
Division name Department of Medicine and Bioregulatory
Address 3-1-1, Maidashi, Higashi-ku, Fukuoka City, 812-8582 Japan
TEL 092-642-5284
Homepage URL
Email kanakudo@med.kyushu-u.ac.jp

Sponsor
Institute Department of Medicine and Bioregulatory, Graduate School of Medical Sciences, Kyushu University
Institute
Department

Funding Source
Organization Department of Medicine and Bioregulatory, Graduate School of Medical Sciences, Kyushu University
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 12 Month 10 Day

Progress
Recruitment status Recruiting
Date of protocol fixation
2016 Year 12 Month 10 Day
Anticipated trial start date
2016 Year 12 Month 10 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information non

Management information
Registered date
2016 Year 11 Month 30 Day
Last modified on
2016 Year 11 Month 30 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028794